Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Optimi Health Corp (OPTHF)

Optimi Health Corp (OPTHF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade OPTHF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1860 +45.91%
on 04/18/24
0.2800 -3.07%
on 05/09/24
+0.0860 (+46.39%)
since 04/17/24
3-Month
0.1531 +77.27%
on 03/22/24
0.2800 -3.07%
on 05/09/24
+0.0274 (+11.23%)
since 02/16/24
52-Week
0.1100 +146.73%
on 12/06/23
0.4300 -36.88%
on 01/03/24
+0.1091 (+67.22%)
since 05/17/23

Most Recent Stories

More News
Psychedelic Drugs Prove Their Worth In Clinical Trials

Novel psychedelic drugs have continuously proven their worth in clinical trials. Just recently, one company revealed that it was in the process of finalizing its Phase 1 first-in-human clinical trial plan...

OPTI.CN : 0.3650 (+2.82%)
ATAI : 1.7500 (-5.91%)
MNMD : 8.35 (-3.47%)
MMED.NE : 14.9000 (+9.48%)
CMPS : 7.94 (-0.63%)
OPTHF : 0.2699 (+1.85%)
CYBN : 0.3424 (-2.73%)
Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease

A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer’s disease, announcing recently that it has gotten approval from Argentina’s regulators to begin a Phase ll clinical...

OPTI.CN : 0.3650 (+2.82%)
SEEL : 1.88 (-19.66%)
NUMI.TO : 0.0700 (unch)
NUMIF : 0.0500 (-7.58%)
ATAI : 1.7500 (-5.91%)
OPTHF : 0.2699 (+1.85%)
TNXP : 0.1979 (+8.98%)
TAK : 13.22 (-0.68%)
Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer’s Disease

FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – October 5, 2022 – A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer’s disease,...

SEEL : 1.88 (-19.66%)
TAK : 13.22 (-0.68%)
ATAI : 1.7500 (-5.91%)
TNXP : 0.1979 (+8.98%)
OPTI.CN : 0.3650 (+2.82%)
OPTHF : 0.2699 (+1.85%)
Scientists Are Studying Psychedelic Drug as a Possible Treatment for Alzheimer's Disease

/PRNewswire/ -- A Toronto-based biotech firm is developing a new psychedelic medicine to cure Alzheimer's disease, announcing recently that it has gotten...

OPTI.CN : 0.3650 (+2.82%)
OPTHF : 0.2699 (+1.85%)
SEEL : 1.88 (-19.66%)
TAK : 13.22 (-0.68%)
ATAI : 1.7500 (-5.91%)
TNXP : 0.1979 (+8.98%)
Optimi Health and ATMA Journey Centers to Send a Clinical Trial Application to Health Canada for Phase I Natural Psilocybin and MDMA

Optimi Health Corp. (CSE:OPTI) (OTCQX:OPTHF) is a Canadian company that makes natural, scalable, and easy-to-get psychedelic and functional mushrooms, as well as synthetic formulations, to help people...

OPTI.CN : 0.3650 (+2.82%)
OPTHF : 0.2699 (+1.85%)
Psychedelics May Make People Less Afraid of Death

FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – September 7, 2022 – According to a new survey by Johns Hopkins Medicine researchers, people’s attitudes toward death...

MMED.NE : 14.9000 (+9.48%)
CYBN.NE : 0.4700 (unch)
MNMD : 8.35 (-3.47%)
OPTI.CN : 0.3650 (+2.82%)
OPTHF : 0.2699 (+1.85%)
CMPS : 7.94 (-0.63%)
CYBN : 0.3424 (-2.73%)
ENVB : 0.8430 (-6.33%)
Psychedelics May Make People Less Afraid of Death

/PRNewswire/ -- According to a new survey by Johns Hopkins Medicine researchers, people's attitudes toward death change after a psychedelic drug experience and...

OPTHF : 0.2699 (+1.85%)
OPTI.CN : 0.3650 (+2.82%)
CYBN : 0.3424 (-2.73%)
CMPS : 7.94 (-0.63%)
MNMD : 8.35 (-3.47%)
ENVB : 0.8430 (-6.33%)
Psychedelics Use Among Young Adults Reaches All-Time High

FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – September 1, 2022 – Young adults are using more hallucinogens than ever.  According to a National Institute of Health...

OPTI.CN : 0.3650 (+2.82%)
OPTHF : 0.2699 (+1.85%)
SEEL : 1.88 (-19.66%)
NUMI.TO : 0.0700 (unch)
NUMIF : 0.0500 (-7.58%)
ATAI : 1.7500 (-5.91%)
TNXP : 0.1979 (+8.98%)
Psychedelics Use Among Young Adults Reaches All-Time High

/PRNewswire/ -- Young adults are using more hallucinogens than ever. According to a National Institute of Health survey, the amount of people between age 19 to...

OPTI.CN : 0.3650 (+2.82%)
NUMI.TO : 0.0700 (unch)
OPTHF : 0.2699 (+1.85%)
SEEL : 1.88 (-19.66%)
NUMIF : 0.0500 (-7.58%)
ATAI : 1.7500 (-5.91%)
TNXP : 0.1979 (+8.98%)
Optimi Health Unveils Canada’s First Natural Therapeutic Psilocybin Product For Approved Patients

Blue Serenity brings science and compassion together, will cement Thomas Hartle’s legacy as a Canadian psychedelic icon Optimi and...

OPTI.CN : 0.3650 (+2.82%)
OPTHF : 0.2699 (+1.85%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.2975
2nd Resistance Point 0.2867
1st Resistance Point 0.2759
Last Price 0.2699
1st Support Level 0.2543
2nd Support Level 0.2435
3rd Support Level 0.2327

See More

52-Week High 0.4300
Fibonacci 61.8% 0.3078
Fibonacci 50% 0.2700
Last Price 0.2699
Fibonacci 38.2% 0.2322
52-Week Low 0.1100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar